First biosciences company lists in Singapore
Wednesday, 23 March, 2005
Dutch company LMA International has become the first biosciences company to list on Singapore's stock exchange, raising S$248 million (AUD$194 million) through the an initial public offering by its Singapore unit, LMA International.
Shares in the company rose to S$0.95 cents on their first day of trading, a premium of 8 per cent on their issue price.
LMA International develops and markets medical equipment -- including a laryngeal mask and other airway management devices.
Noxopharm says paper reveals science behind its immune system platform
Clinical-stage Australian biotech company Noxopharm Limited says a Nature Immunology...
Neurosensing/neurostimulation implants session to be held on Monday
On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics...
argenx and Monash University partner against autoimmune diseases
To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has...
